Spark Therapeutics is a biotechnology company located in Philadelphia, Pennsylvania, specializing in the development of innovative gene therapies. Situated at 3737 Market Street, the company focuses on advancing medical treatments through cutting-edge research and technology aimed at addressing genetic disorders. Its work involves the manipulation and delivery of genetic material to target specific diseases, contributing to the evolving landscape of biopharmaceuticals.
The company’s operations are grounded in a scientific approach to understanding the genetic basis of various health conditions. By leveraging advancements in molecular biology and genetics, Spark Therapeutics seeks to create therapies that can potentially correct or mitigate the effects of inherited diseases. The firm collaborates with research institutions and healthcare professionals to translate laboratory discoveries into clinical applications that benefit patients.
Spark Therapeutics maintains a commitment to rigorous scientific investigation and regulatory compliance, ensuring that its products meet safety and efficacy standards. The company’s presence in Philadelphia positions it within a hub of biomedical innovation, facilitating access to a network of resources and expertise. Through its focused efforts in gene therapy, Spark Therapeutics contributes to the broader field of biotechnology with the goal of improving patient outcomes.
Contact for Spark Therapeutics can be made by calling 855-772-7589, allowing inquiries related to its biotechnology services and ongoing projects. As a participant in the dynamic biotechnology sector, Spark Therapeutics represents a key player in advancing medical science within the Philadelphia region and beyond.


































